Pediatric Early Phase-Clinical Trial Network (PEP-CTN) Members

Photo courtesy of Cincinnati Children's Hospital Medical CenterPediatric Early Phase-Clinical Trial Network (PEP-CTN) is comprised of 21 premier Children’s Oncology Group (COG) pediatric oncology programs in the country that were selected through a peer review process and serves as a national and international model for new agent development in pediatric oncology. This dedicated consortium provides the necessary infrastructure for the conduct of pediatric early phase clinical trials and pharmacokinetic and biomarker studies.